• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » MassDevice On Call: Economists back healthcare reform

MassDevice On Call: Economists back healthcare reform

November 15, 2010 By MedCity News

MassDevice On Call

Economists back healthcare reform. A group of 35 economists, including three Nobel laureates, asked a U.S. judge for permission to file an amicus brief backing the Obama administration’s bid to end a lawsuit challenging its healthcare overhaul, according to Bloomberg Businessweek. Each one of the economists did not initially support the passage of the Affordable Care Act, but "they all believe that reform of the health care system is essential to constraining the growth of health care spending and providing security to all Americans," they wrote in the motion to file the brief.

Another drug giant looks to buy Genzyme. Rumors surfaced over the weekend that Japan’s Takeda Pharmaceuticals (TKO:4502) is in the running for Genzyme Corp. (NSDQ:GENZ), although an offer is unlikely, according to The Wall Street Journal. The Cambridge, Mass.-based biotech giant resisted a recent takeover bid from French pharmaceuticals giant Sanofi-Aventis SA (NYSE:SNY).

MedCity News logo

Hoover Institution offers an alternative to healthcare reform. The Hoover Institution has released Reforming America’s Health Care System: The Flawed Vision of ObamaCare, edited by health policy expert Dr. Scott Atlas — a book that discusses what to expect from the recent health reform legislation and alternatives that should be considered.

And Democrats offer small business relief. Senate Democrats led by Senate Finance Committee Chairman Max Baucus (D-Mont.) said Friday they’re prepared to repeal the so-called 1099 provision in the health care reform law that has riled small businesses over concern it’s too burdensome, according to Politico. The provision could have raised $17 billion to pay for reform.

Maybe that’s why bipartisan health reform is impossible. Washington Post columnist Ezra Klein offers this perspective on decades of political partisanship surrounding healthcare reform: “Democrats moved right every time they failed. And Republicans moved further right every time Democrats tried."

Everyday Health yanks IPO. Everyday Health Inc., which operates 25 health-related websites including one for Jillian Michaels of Biggest Loser fame, said it would withdraw its bid to go public, instead raising $20 million in Series G funding to acquire other companies and await better market conditions, according to Dow Jones VentureWire.

Pioneering cardiologist dies. Dr. Richard Bing, a pioneering cardiologist whose research led to new understandings of blood flow, congenital heart disease and the mechanics of the heart, died today at his home in La Canada, California, according to The New York Times. He was 101.

Filed Under: Business/Financial News, Healthcare Reform, News Well

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy